N-Hydroxy-5'-O-isobutyryl-3,4-dihydrocytidine(CAS: 2349386-89-4)

N-Hydroxy-5'-O-isobutyryl-3,4-dihydrocytidine (CAS: 2349386-89-4) falls under the regulatory guidelines of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH in the European Union, and FDA/EPA in the United States for environmental and safety considerations. Specific handling and storage instructions must comply with local and international regulations.

There are alternative reagents and synthetic pathways that can be explored in the synthesis of analogs such as N-Hydroxy-5'-O-isobutyryl-3,4-dihydrocytidine (CAS: 2349386-89-4). Common alternatives include various isomers and structurally similar compounds that can be used depending on the specific application and desired properties.

The market for N-Hydroxy-5'-O-isobutyryl-3,4-dihydrocytidine (CAS: 2349386-89-4) is currently focused on its applications in pharmaceutical research and development, particularly in nucleoside analogs for antiviral and anticancer therapies. Research trends indicate increasing interest in its potential for therapeutic use due to its unique chemical structure.

Waste containing N-Hydroxy-5'-O-isobutyryl-3,4-dihydrocytidine (CAS: 2349386-89-4) should be collected and disposed of in accordance with local regulations and environmental protection guidelines. Proper incineration or professional waste disposal services are recommended to ensure environmental safety and compliance.